References
- Locatelli F., Bommer J., London G.M., Martin-Malo A., Wanner C., Yaqoob M., Zoccali C. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol. Dial. Transplant. 2001; 16: 459–468
- Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001; 19: 53–61
- Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55: 648–658
- Yeun J.Y., Levine R.A., Mantadilok V., Kaysen G.A. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am. J. Kidney Dis. 2000; 35: 469–476
- Kaysen G.A., Dubin J.A., Muller H.G., Mitch W.E., Levin N.W. The HEMO Group. Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int. 2001; 60: 2360–2366
- Irish A. Cardiovascular disease, fibrinogen and the acute phase response associations with lipids and blood pressure in patients with chronic renal failure. Atherosclerosis 1998; 137: 133–139
- Borawski J., Naumnik B., Pawlak K., Mysliwiec M. Endothelial dysfunction marker von Willebrand factor antigen in hemodialysis patients: associations with predialysis blood pressure and the acute phase response. Nephrol. Dial. Transplant. 2001; 16: 1442–1447
- Zoccali C., Bode-Boger S., Mallamaci F., Benedetto F., Tripepi G., Malatino L., Cataliotti A., Bellanuova I., Fermo I., Frolich J. Plasma concentration of asymmetrical dimetyloarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358: 213–217
- Kario K., Matsuo T., Kobayashi H., Matsuo M., Asada R., Koide M. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb. Hemost. 1995; 74: 1020–1024
- Borawski J., Mysliwiec M. The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients. Nephron 2001; 89: 281–383
- Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Cutrupi S., Parlongo. S., Malatino L.S., Bonanno G., Seminara G., Rapisarda F., Fatuzzo P., Buemi M., Nicocia G., Tanaka S., Ouchi N., Kihara S., Funahashi T., Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 2002; 13: 134–141
- Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999; 340: 448–454
- Koj A. The Acute-Phase Response to Injury and Infection. Definition and classification of acute-phase proteins, A.H. Gordon, A. Koj. Elsevier Science Publishers, Amsterdam 1985; 139–144